19 research outputs found

    TGO growth behavior of modified environmental barrier coating systems

    Get PDF
    Please click Additional Files below to see the full abstrac

    EGFR and COX-2 protein expression in non-small cell lung cancer and the correlation with clinical features

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>To evaluate the expression of EGFR and COX-2 and their correlation with prognosis in NSCLC</p> <p>Methods</p> <p>The paraffin embedded tumor samples of 50 NSCLC patients receiving radical resection were analyzed immunohistochemically for EGFR and COX-2 expression and their prognostic values were explored.</p> <p>Results</p> <p>The positive rate of EGFR protein in NSCLC tumor cells was 46%, which was significantly higher than its expression in normal lung (p = 0.0234) and paracancerous tissues (p = 0.020). EGFR expression was significantly higher in nodal positive than in nodal negative patients (p = 0.04). The mean survival time for EGFR positive patients (31 months) was significantly lower than that for patients with EGFR negative expression (48 months) (p = 0.008,). In patients receiving post-operation thoracic irradiation, the mean survival time for EGFR positive patients was significantly lower than that for patients without EGFR positive expression (25 vs. 48 months, P = 0.004). The positive rate of COX-2 protein expression in NSCLC tumor cells was 90%, which was significantly higher than that in normal tissue(p = 0.00) and paracancerous tissue (p = 0.00). There was no correlation between COX-2 expression and patient survival, and no correlation between COX-2 and EGFR protein expression (P = 0.555).</p> <p>Conclusions</p> <p>COX-2 and EGFR are over-expressed in NSCLC. EGFR is an independent prognostic factor and a predictive factor for radiotherapy response in NSCLC.</p

    Precursor and processing conditions to make dense ceramic coatings using the solution precursor plasma spraying process

    No full text
    The objective of this research is to determine the precursor and processing conditions to produce nanograined ceramic coatings with high density and hardness using the Solution Precursor Plasma Spray (SPPS) process. These dense coatings would find potential applications as optical ceramics, wear resistant coatings and bioactive coatings. ^ Basic operating principles needed to create relatively dense coatings using the SPPS process have been discovered. These principles were then used to produce two new precursors and associated processing methods. It has been shown that dense coatings can be best produced if deposits arriving at the substrate are fully Incited. Multiple factors have been experimentally identified that provide dense coatings, including: (1) high solution concentration: (2) low melting temperature compositions; (3) large diameter gun nozzles: (4) high gun power and low liquid feed rates, (5) better entrainment of the droplets in the hot part of the plasma jet. ^ Based on these principles of dense coating formation, dense eutectic Al2O3-YSZ SPPS coatings were produced. The as-deposited coating has 95.6% density and hardness of 11.8 GPa. The thermal stability of as-sprayed dense eutectic Al2O3-7YSZ coatings was examined. High temperature heat treatments of the coating show that both the phase and nano-grain structure are very stable. The nanocomposite Al 2O3-7YSZ coatings are highly grain growth resistant due to the increased diffusion path of species along interphase boundaries. ^ The reproducibility of the principles to make dense ceramic coatings was successfully demonstrated by deposition of a low melting point TiO 2 coating that has desirable biological properties. A dense TiO 2 coating (96%) with a hardness of 7.6 GPa was achieved. ^ The conditions for making dense coatings have been identified. The discovery and demonstration of basic principles for making dense SPPS coatings is a fundamental advancement of the state of the art for SPPS coating technology.

    Thermal Cycling Behavior of Air Plasma-Sprayed and Low-Pressure Plasma-Sprayed Environmental Barrier Coatings

    No full text
    Yb2Si2O7/Si environmental barrier coatings (EBCs) were produced by air plasma spray (APS) and low-pressure plasma spray (LPPS) processes. The phase composition, microstructure, and bonding strength of APS and LPPS EBCs were investigated. Thermal cycling tests were performed in air and in steam atmosphere respectively at 1316 °C for both APS and LPPS EBCs. There is no coating failure in air atmosphere for both APS and LPPS EBCs after 900 cycles. In contrast, APS EBCs have an average life of 576 cycles in a steam cycling test in 90% H2O + 10% air at 1316 °C while LPPS EBCs survived 1000 cycles without failure. The superior durability of the LPPS EBCs compared to APS EBCs in the same steam cycling environment is attributed to the significantly reduced thermally grown oxide (TGO) growth rate because of the denser and crack-free microstructure, higher bonding strength, and reduced coefficient of thermal expansion (CTE) mismatch (less Yb2SiO5 phase) in the LPPS Yb2Si2O7/Si EBCs

    A Novel Internal Fixation Design for the Treatment of AO/OTA‐31A3.3 Intertrochanteric Fractures: Finite Element Analysis

    No full text
    Objective AO/OTA 31‐A3.3 intertrochanteric fracture is the most unstable type of intertrochanteric fracture, with a high rate of postoperative complications and implant failure. We have designed a new intramedullary fixation, proximal femoral totally bionic nail (PFTBN), for the treatment of A3.3 intertrochanteric fracture. To test its biomechanical performance, we adopted the method of finite element analysis and compared PFTBN with proximal femoral nail antirotation (PFNA) and proximal femoral bionic nail (PFBN, another internal fixation we previously designed for stable intertrochanteric fractures). Methods Mimics, 3‐matic, ANSYS, and other software were used to construct a highly precise and realistic 3D digital model of the human femur. An AO/OTA 31‐A3.3 intertrochanteric fracture of the femur was constructed according to the 2018 classification of AO/OTA, and then assembled with PFNA, PFBN and PFTBN models, respectively. The stress distribution and displacement distribution of the three groups of constructs were tested under three times the body weight load and one‐foot standing configuration. Results In terms of maximum stress and maximum displacement, the PFTBN group outperforms the PFBN group, and the PFBN group, in turn, surpasses the PFNA group. The maximum stress of PFTBN group was 408.5 Mpa, that of PFBN group was 525.4 MPa, and that of PFNA group was 764.3 Mpa. Comparatively, the maximum stress in the PFTBN group was reduced by 46.6% when contrasted with the PFNA group. Moreover, the stress dispersion within the PFTBN group was more evenly distributed than PFNA group. Regarding maximum displacement, the PFTBN group displayed the least displacement at 5.15 mm, followed by the PFBN group at 7.32 mm, and the PFNA group at 7.73 mm. Notably, the maximum displacement of the PFTBN group was 33.4% less than that observed in the PFNA group. Additionally, the relative displacement between the fragment and implant at the tip of pressure screw or helical blade was 0.22 mm in the PFTBN group, 0.34 mm in the PFBN group, and substantially higher 0.51 mm in the PFNA group. Conclusion The “lever‐reconstruction‐balance” theory provides a new perspective for us to understand the mechanical conduction of the proximal femur. Compared with PFNA, in treating A3.3 intertrochanteric fractures PFTBN can better reconstruct the function of lateral wall, restore physiological mechanical conduction, increase postoperative stability, and finally reduce the risk of postoperative cut‐out and implant failure. It might be a better alternative for the treatment of A3.3 intertrochanteric fracture

    Integrative Bone Metabolomics—Lipidomics Strategy for Pathological Mechanism of Postmenopausal Osteoporosis Mouse Model

    No full text
    Abstract Osteoporosis, characterized by bone mass reduction and increased fractures, has become a global health problem that seriously affects the health of people, especially postmenopausal women; however, the current pathogenesis of postmenopausal osteoporosis (PMOP) has not been thoroughly elucidated to date. In this study, bilateral ovariectomy was performed to establish an OVX mouse model of osteoporosis. UPLC-Q-TOF-MS-based lipidomics in combination with metabolomics were used to analyze the femur tissue of osteoporosis mice. We found that 11 polar metabolites and 93 lipid metabolites were significantly changed and were involved in amino acid metabolism, nucleotide metabolism and lipid metabolism. Among the lipids, fatty acyls, glycerolipids, glycerophospholipids, sphingolipids and sterols showed robust changes. These results revealed that several metabolic disorders caused by changes in the hormone levels in OVX, especially disordered lipid metabolism, are closely related to the imbalance between bone resorption and formation and may underlie the development of PMOP. The data generated via lipidomics and metabolomics presented in this study shows good applicability and wide coverage in the construction of the metabolic profile of bone tissue. Therefore, this approach may provide the pathway focusing and data support at the metabolite level for the in-depth mechanism of PMOP
    corecore